Piperidolate
Jump to navigation
Jump to search
Clinical data | |
---|---|
Trade names | Dactil |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.318 |
Chemical and physical data | |
Formula | C21H25NO2 |
Molar mass | 323.436 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Piperidolate is a pharmaceutical drug used to treat the symptoms of gastrointestinal disorders including gastric and duodenal ulcers, gastritis, enteritis, gallstones, cholecystitis, and biliary dyskinesia.[1] It acts as an antimuscarinic agent.[2][3] It was first approved in 1954 and is no longer marketed in the United States.[1]
References
- ^ a b "Piperidolate". Inxight Drugs. National Center for Advancing Translational Sciences.
- ^ "Piperidolate". drugs.com.
- ^ Vardanyan R (2017). Piperidine-Based Drug Discovery. Elsevier Science. p. 130. ISBN 978-0-12-813428-3.
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Piperidines
- Muscarinic antagonists
- Carboxylate esters
- All stub articles
- Gastrointestinal system drug stubs